Class action lawsuit filed against Organogenesis has been dismissed.CANTON, Mass.--(BUSINESS WIRE)--March 14, 1996--Organogenesis Inc. (AMEX AMEX See: American Stock Exchange : ORG) announced today that the class action lawsuit class action lawsuit A lawsuit in which one party or a limited number of parties sue on behalf of a larger group to which the parties belong. For example, investors may bring a class action lawsuit against a brokerage firm that has actively promoted a tax filed against the company alleging federal securities law violations has been dismissed. The dismissal was without prejudice Without any loss or waiver of rights or privileges. When a lawsuit is dismissed, the court may enter a judgment against the plaintiff with or without prejudice. When a lawsuit is dismissed without prejudice , and no payment or compensation of any sort has been made to the plaintiff or his counsel in connection with the dismissal of this action. Organogenesis organogenesis /or·ga·no·gen·e·sis/ (or?gah-no-jen´e-sis) the origin and development of organs.organogenet´ic or·gan·o·gen·e·sis n. The formation and development of the organs of living things. designs, develops and manufactures innovative medical therapeutics using living human cells and natural connective tissue components. Organogenesis' tissue-engineered products, such as Graftskin are designed to promote the establishment and growth of new tissues that maintain, restore or improve biological function. Its product development focus includes wound care, urology, cardiovascular surgery and general surgery. CONTACT: Organogenesis, Canton Carol S. Hausner, 617/575-0898 X3007 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion